Georgia - Re-Export of Heparin for Therapeutic Use
Since 2010, Georgia Re-Export of Heparin for Therapeutic Use grew 221.2% year on year. At $30,743.97 in 2014, the country was number 8 among other countries in Re-Export of Heparin for Therapeutic Use. Georgia is overtaken by United Arab Emirates, which was ranked number 7 at $46,048.8 and is followed by Cyprus with $10,187.59. United States ranked the highest with $4,598,060.57 in 2019, that is -5.2% compared to 2018. Canada, Barbados and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. Georgia recorded the best 5 years average growth at +221.2% per year, while United States was the worst growing country at -29.7% per year.
Loading...
Date | US Dollars |
---|---|
2014 | 30,743.97 |
2013 | 2,629.00 |
2012 | 36,315.00 |
2011 | |
2010 | 289.00 |
Download all data from 2010 to 2014
How does Georgia rank in Re-Export of Heparin for Therapeutic Use?
# | 11 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
United States
|
4,598,060.57 | 2019 | -5.2 % | -29.7 % | View data | |
2 |
#2
Canada
|
1,368,644.83 | 2019 | +95.1 % | +28.6 % | View data | |
7 |
#7
United Arab Emirates
|
46,048.80 | 2019 | -14.7 % | +23.1 % | View data | |
8 |
#8
Georgia
|
30,743.97 | 2014 | +1,069.4 % | +221.2 % | View data | |
9 |
#9
Cyprus
|
10,187.59 | 2018 | NA | NA | View data |